Accessibility Menu
Stryker logo

Stryker(NYSE) SYK

Market Cap$124.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1983)+77,889%
5 Year+27%
1 Year-16%
1 Month+4%
$341.08
+4.72%
+15.38Today
After hours$341.08+$0.00 (+0.00%)
Stryker last closing stock price
MetricPriceDate
Last closeUSD 325.702026-07-31
Stryker stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.38%USD 330.252026-07-24
1 month+3.93%USD 313.392026-07-01
3 month+10.8%USD 293.952026-05-01
Year to date-6.83%USD 349.592025-12-31
1 year-16.22%USD 388.772025-07-31
3 year+20.09%USD 271.222023-08-01
5 year+26.62%USD 257.232021-07-30
Since inception+77,888.76%USD 0.421983-06-21

Stryker Financials at a Glance

Market Cap

$124.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$25.84B

Net Income (TTM)

$3.73B

EPS (TTM)

$9.65

P/E Ratio

33.77

Dividend

$3.48

Beta (Volatility)

0.80 (Low)

Price

$341.08

Volume

1,841,050.085

Open

$332.94

Previous Close

$325.70

Daily Range

$330.60 - $341.75

52-Week Range

$281.00 - $396.86

Estimated Earnings Date

Oct 29, 2026

SYK News

Robots taking care of plants in a greenhouse.jpg

The Largest Robotics Companies in the World

Lyle DalyJun 15, 2026
Woman in chair surrounded by question marks under a large red arrow trending down.

Why Stryker Stock Popped Today

Rich SmithJan 6, 2026
what-does-johnson-and-johnson-own-infographic

What Companies Does Johnson & Johnson Own?

Matt DiLalloDec 30, 2025
Foolcom-Featured.png

Stryker (SYK) Q2 Revenue Jumps 11%

Motley Fool Markets TeamAug 2, 2025
person looking at computer working on life science material.jpg

Investing in Life Sciences Stocks

Keith SpeightsOct 16, 2024
A doctor and patient at an appointment.

Is This MedTech Giant a Buy for Dividend Investors?

Kody KesterAug 9, 2023
A doctor and patient at an appointment.

This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?

Kody KesterJun 21, 2023
A doctor and patient talk to each other during an appointment.

2 Healthcare Stocks That Could Help Set You Up for Life

Kody KesterJun 19, 2023
Page 1

SYK: Motley Fool Moneyball Superscore

80

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stryker

Stryker makes medical devices that help doctors treat injuries and illnesses. Its products support surgeries, joint replacements, and emergency care in hospitals. These tools help patients recover movement or survive critical events.

Products and Services

  • MedSurg and Neurotechnology (60% of 2024 revenue): Surgical tools, patient handling, and devices for brain and nerve procedures, sold to hospitals and clinics.
  • Orthopaedics (40% of 2024 revenue): Implants for hip, knee, and shoulder replacements, plus trauma and spine surgery products, used by orthopedic surgeons.
  • Robotic Surgery: Mako SmartRobotics system assists doctors in joint replacement surgeries, aiming for more precise outcomes.
  • Emergency Medical Equipment: LIFEPAK defibrillators and patient transport devices, used by emergency responders and hospitals.
  • Digital Health and AI: Virtual care platforms and clinical communication tools, supporting hospital staff and patient monitoring.

Growth and Expansion

  • Acquired Vertos Medical (2024) for pain management devices and care.ai (2024) for virtual care technology.
  • Expanded Mako SmartRobotics to over 45 countries by 2024, with 1.5 million procedures performed.
  • Launched new products in 2024, including the SurgiCount+ system and Triathlon Hinge knee.
  • Announced acquisition of Inari Medical (2025) for thrombectomy devices, and sale of U.S. Spinal Implants business.
  • Entered new markets and broadened product lines through targeted acquisitions and product launches since 2022.

What Makes Stryker Stand Out

Stryker sells directly to hospitals and doctors in 75 countries, using both its own teams and distributors. The company invests heavily in research, focusing on robotics and digital health. Its broad product range and global reach help it serve many healthcare needs.

Five Things You Need to Know

  • Net sales were $22.60 billion in 2024, up 10.2% from 2023.
  • MedSurg and Neurotechnology segment grew 11.1% in 2024, reaching $13.52 billion.
  • Orthopaedics segment sales rose 8.9% in 2024, totaling $9.08 billion.
  • International sales made up 25% of 2024 revenue; U.S. sales were 75%.
  • Operating income was $3.69 billion in 2024, down 5.1% from 2023.

Bottom Line

Stryker has grown by expanding its product range and entering new markets. Its focus on innovation and global distribution supports steady business evolution.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

56,000

CEO

Kevin A. Lobo, MBA

Website

www.stryker.com

Headquarters

Portage, MI 49002, US

SYK Financials

Key Financial Metrics (TTM)

Gross Margin

65.17%

Operating Margin

22.03%

Net Income Margin

14.43%

Return on Equity

16.36%

Return on Capital

12.61%

Return on Assets

7.78%

Earnings Yield

2.96%

Dividend Yield

1.07%

Payout Ratio

35.32%

Stock Overview

Market Cap

$124.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

383.36M

Volume

1.84M

Avg. Volume

2.80M

Financials (TTM)

Gross Profit

$16.84B

Operating Income

$5.69B

EBITDA

$6.26B

Operating Cash Flow

$5.53B

Capital Expenditure

-$823.00M

Free Cash Flow

$4.70B

Cash & ST Invst.

$3.48B

Total Debt

$14.94B

Stryker Performance Analysis

Stryker annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 18,449,000,0007.8%
20232023-12-31USD 20,498,000,00011.1%
20242024-12-31USD 22,595,000,00010.2%
20252025-12-31USD 25,116,000,00011.2%
Stryker sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-300.6%
Q42025-12-3118.4%
Q12026-03-31-16.1%
Q22026-06-309.5%
Stryker annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 6.1718.3%
20232023-12-31USD 8.2533.7%
20242024-12-31USD 7.76-5.9%
20252025-12-31USD 8.408.2%
Stryker sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3.1%
Q42025-12-31-0.9%
Q12026-03-31-12.3%
Q22026-06-3071.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$6.59B

+9.4%

Gross Profit

$4.50B

+19.9%

Gross Margin

68.27%

N/A

Market Cap

$124.86BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.23M

N/A

Employees

56,000

N/A

Net Income

$1.28B

+44.3%

EBITDA

$1.56B

+6.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$3.48B

+41.1%

Total Debt

$14.94B

-12.8%

Accounts Receivable

$3.74B

-4.5%

Inventory

$5.52B

+4.4%

Long Term Debt

$14.19B

-6.7%

Short Term Debt

$750.00M

-60.7%

Return on Assets

7.78%

N/A

Return on Invested Capital

13.80%

N/A

Free Cash Flow

$1.06B

+14.1%

Operating Cash Flow

$1.26B

+13.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRTXVertex Pharmaceuticals Incorporated
$470.77-1.33%
MDTMedtronic plc
$86.70+1.53%
DHRDanaher Corporation
$197.52+1.30%
PFEPfizer Inc.
$25.05+0.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.38-0.05%
NVDANvidia
$207.26+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.84+0.07%
INTCIntel
$90.68+0.01%

Questions About SYK

What is the current price of Stryker?

Stryker is trading at $340.68 per share.

What is the 52-week range for Stryker?

Over the past 52 weeks, Stryker has traded between $281.00 and $396.86.

How much debt does Stryker have?

As of the most recent reporting period, Stryker reported total debt of $15.45B.

How much cash does Stryker have on hand?

Stryker reported $3.39B in cash and cash equivalents in its most recent financial results.

What is Stryker’s dividend yield?

Stryker currently has a dividend yield of 1.07%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services